Related Experiment Video
Updated: Sep 13, 2026

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
Human immune responses to the UK human anthrax vaccine
L W Baillie1, K Fowler, P C Turnbull
1DERA Chemical and Biological Defence Sector, Porton Down, Salisbury, Wilts, UK.
Abstract:
The IgG anti-protective antigen subclass antibody response of individuals who had been infected with anthrax was compared with that of healthy individuals immunized with the UK licensed anthrax vaccine. The predominant subclass in both groups was IgG1. In addition, IgG3 was seen in convalescent serum while vaccinees produced IgG2, IgG3 and IgG4 subclass. The significance of these results is discussed. Further work is required to determine the role of antibodies in mediating protective immunity in man.
More Related Videos
06:34An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers
Published on: December 1, 2017
13:47Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
Published on: May 19, 2020
Related Concept Videos
Humoral Immune Responses
Cross-reactivity
Vaccinations
Vaccines
Inhalation Anthrax
Hypersensitivity Reactions: Immune-Complex Reactions